How to play potential rural bounce-back
Hindustan Unilever, the barometer of India’s rural and urban consumption, has been an underperformer among the large-cap stocks in 2023. The share price fell 2.5%, while the NSE Nifty gained…
Why banks could drive stock markets
For an economy to be booming, you need big banks. America has JP Morgan Chase and Bank of America. China has state-owned banks that dwarf most emerging market banks by…
Midcaps stocks vs Large caps – how to seize opportunities.
If you want to build an aggressive portfolio, you must take risks. In the early days of your work life, that is possible. Even then, your investments need the proper…
Why companies with FDI are good for you
Stock picking is an art. You must know the right time to get in or out. It is a skill you can acquire after years of practice. For most of…
COVID FEARS RESURFACE – AN OPPORTUNITY IN CRISIS?
As we bring the year to a close, fears of another Covid Wave are back. Another China variant with supposedly higher infecting potency is bringing back the ghosts of the…
Making sense of the India opportunity
The world is a troubled place right now. There is a war in Europe, a resurgent pandemic in China, US and Europe, and soaring inflation due to rising energy costs…
Alphaniketan is an Investors Education initiative from Alphaniti
Opportunity in adversity
The story of India’s pharmaceuticals industry in the context of COVID-19
Not every extraordinary situation turns out to be unfavourable for an economy. There are sectors which benefit amply from extraordinary situations like the pandemic. One such sector is pharmaceuticals. The pandemic which had destroyed demand in most key sectors has clearly brought India’s pharmaceuticals sector at the centre of most analysis and predictions.
(more…)